Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Oleoylethanolamide (OEA) is a lipid mediator naturally produced in the small intestine and other tissues, and it has been studied for its role in fat metabolism and appetite regulation. Scientific evidence suggests that OEA acts as a peroxisome proliferator-activated receptor-alpha (PPAR-α) agonist, which is involved in the regulation of lipid metabolism. Preclinical studies in rodents have consistently shown that OEA administration reduces food intake, promotes lipolysis, and enhances fat oxidation. These effects are believed to arise from OEA’s ability to activate PPAR-α and modulate signaling pathways that influence satiety and energy expenditure.

Small-scale human studies have also investigated OEA’s effects. For example, a randomized controlled trial published in 2018 found that OEA supplementation in overweight individuals led to reductions in body weight and waist circumference compared to placebo, although the sample size was limited. Other human studies are limited in number and scope, and more robust, large-scale clinical trials are needed to confirm these findings and establish effective dosing.

Overall, current evidence justifies the use of OEA to support fat metabolism based on mechanistic understanding and early clinical results. However, while the preclinical data are strong, the clinical evidence is still emerging and not yet conclusive, which is reflected in the moderate evidence rating.

More about Oleoylethanolamide
More about Fat Metabolism (poor)

Other ingredients used for Fat Metabolism (poor)

Other health conditions supported by Oleoylethanolamide

Products containing Oleoylethanolamide